Cargando…
Intravenous Thrombolytics in the Treatment of Acute Ischemic Stroke
PURPOSE OF REVIEW: To review the current evidence and ongoing clinical trials evaluating the efficacy and safety of tenecteplase (TNK), an alternative tissue plasminogen activator (tPA), in the acute management of arterial ischemic stroke (AIS). To date, alteplase is the only tPA approved by the Uni...
Autores principales: | Alhadid, Kenda, Oliveira, Lara, Etherton, Mark R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807245/ https://www.ncbi.nlm.nih.gov/pubmed/36618509 http://dx.doi.org/10.1007/s11936-022-00973-2 |
Ejemplares similares
-
Medico-Legal Aspects of Using Tissue Plasminogen Activator in Acute Ischemic Stroke
por: Bruce, Nhu T., et al.
Publicado: (2011) -
The Role of Hospitalists in the Acute Care of Stroke Patients
por: Amin, Alpesh, et al.
Publicado: (2010) -
Principled Versus Statistical Thinking in Diagnosis and Treatment of Stroke
por: Helgason, Cathy M., et al.
Publicado: (2010) -
Update on Antithrombotic Therapy for Stroke Prevention in Atrial Fibrillation
por: Abcede, Hermelinda G., et al.
Publicado: (2010) -
Functional Outcome Measures of Recombinant Tissue Plasminogen
Activator–Treated Stroke Patients in the Telestroke Technology
por: Gainey, Jordan, et al.
Publicado: (2018)